These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 1103897)
1. [Human pharmacokinetics and metabolism of 14C-labeled gliquidone (AR-DF 26)]. Kopitar Z Arzneimittelforschung; 1975 Sep; 25(9):1455-60. PubMed ID: 1103897 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic behaviour of gliquidone (AR-DF 26), a new sulfonyl urea. Summary of the studies so far (author's transl)]. Kopitar Z; Koss FW Arzneimittelforschung; 1975; 25(12):1933-8. PubMed ID: 1243665 [TBL] [Abstract][Full Text] [Related]
3. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus. von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of 14C-glipentide, a new antidiabetic, after oral and intravenous administration. Chanal JL; Calmette MT; Khiat M; Rimbau V; Vera A Arzneimittelforschung; 1977; 27(4):852-6. PubMed ID: 577463 [TBL] [Abstract][Full Text] [Related]
5. Metabolism, kinetics and metabolic activity of the beta-cytotropic antidiabetic 4-(5-isobutylpyrimidinyl-2)-sulphamylphenylacetic acid-3-chloro-6-methoxyanilide sodium (glydanile sodium) in man after oral and intravenous administration. Gerhards E; Berger D; Peters S Arzneimittelforschung; 1976 Feb; 26(2):278-86. PubMed ID: 947213 [TBL] [Abstract][Full Text] [Related]
6. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon. Cameron BD; Draffan GH; Dunsire JP; Zimmer A Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of AR-L 115 BS in the rat (author's transl)]. Busch U Arzneimittelforschung; 1981; 31(1a):204-9. PubMed ID: 7195222 [TBL] [Abstract][Full Text] [Related]
8. [Biochemical studies with oxitropium bromide. 2. Pharmacokinetics and metabolism in humans]. Wahl D; van Wayjen RG; van den Ende AA Arzneimittelforschung; 1985; 35(1A):266-72. PubMed ID: 4039167 [TBL] [Abstract][Full Text] [Related]
15. Absorption, metabolism, and excretion of [14C]MK-0767 (2-methoxy-5-(2,4-dioxo-5-thiazolidinyl)-N-[[4-(trifluoromethyl)phenyl] methyl]benzamide) in humans. Kochansky CJ; Rippley RK; Yan KX; Song H; Wallace MA; Dean D; Jones AN; Lasseter K; Schwartz J; Vincent SH; Franklin RB; Wagner J Drug Metab Dispos; 2006 Sep; 34(9):1457-61. PubMed ID: 16772365 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of the trichomonacidal agent ZK 25 095 in 6 normal subjects following intravenous and oral administration (author's transl)]. Kessler HJ; Schulz V; Wagener B Arzneimittelforschung; 1976; 26(7):1371-5. PubMed ID: 827298 [TBL] [Abstract][Full Text] [Related]
17. Disposition and metabolism of [14C]-haloperidol in rats. Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of radioactively labeled glisoxepide in the animal]. Kolb KH; Schulze PE; Speck U; Acksteiner B Arzneimittelforschung; 1974 Mar; 24(0):397-403. PubMed ID: 4211553 [No Abstract] [Full Text] [Related]